Icade (XPAR:ICAD)
€ 27.88 0.2 (0.72%) Market Cap: 2.11 Bil Enterprise Value: 5.37 Bil PE Ratio: 0 PB Ratio: 0.42 GF Score: 65/100

Half Year 2023 Icade SA Earnings Call Transcript

Jul 24, 2023 / 08:00AM GMT
Release Date Price: €36.88 (-1.60%)
Nicolas Joly
Icade - CEO

Good morning everyone. I am Nicolas Joly. I'm here with Victoire Aubry, our CFO. It's a real pleasure for me to be here today. We have several subjects on the agenda. We will start by giving you an update on the disposal of Icade Sante, we will then follow with our half year performance and financial results before I give you my first perspective after the first 100 days and we will conclude with our outlook for the year. But let's start our presentation with Slide 5. When I joined as new CEO of Icade, I had 3 priorities. First one was to deliver Icade Sante's Stage 1 disposal. The second is to perform a complete deep dive on our portfolio and assess the situation. And the third will be to leverage that assessment to design the future trajectory of the group. So let me now lead you through the key takeaways of the period that I'd like to share with you.

Unsurprisingly, we want to discuss first the latest updates on the sale of Icade Sante. The key new piece of information is that as planned, Stage 1 is completed as of July 5, date by which we sold 63% of our stake in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot